ITIH4 and HIV-1 infection: An increasing number of studies have illustrated that in addition to providing a shield to avoid immune responses, gp120 glycans can be the major “sites of vulnerability” targeted by broadly neutralizing antibodies (bNAbs)6–8, which are the most effective and promising solution for protection against infection and suppression of established HIV-1 infection.